Crescita Therapeutics Inc. (TSX: CTX)
0.640
+0.010 (1.59%)
Aug 22, 2024, 1:48 PM EDT
Crescita Therapeutics Revenue
Crescita Therapeutics had revenue of 4.09M CAD in the quarter ending June 30, 2024, a decrease of -20.81%. This brings the company's revenue in the last twelve months to 16.84M, down -22.84% year-over-year. In the year 2023, Crescita Therapeutics had annual revenue of 17.52M, down -25.52%.
Revenue (ttm)
16.84M
Revenue Growth
-22.84%
P/S Ratio
0.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 17.52M | -6.00M | -25.52% |
Dec 31, 2022 | 23.53M | 6.76M | 40.29% |
Dec 31, 2021 | 16.77M | 1.13M | 7.22% |
Dec 31, 2020 | 15.64M | -6.70M | -29.98% |
Dec 31, 2019 | 22.34M | 5.71M | 34.33% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch + Lomb Corporation | 6.15B |
Curaleaf Holdings, Inc. | 1.86B |
Bausch Health Companies Inc. | 12.59B |
Tilray Brands, Inc. | 1.08B |
dentalcorp Holdings Ltd. | 1.47B |
Cronos Group Inc. | 139.29M |
WELL Health Technologies Corp. | 910.42M |
Sienna Senior Living Inc. | 844.19M |
Crescita Therapeutics News
- 14 days ago - Crescita Therapeutics GAAP EPS of -C$0.05, revenue of C$4.09M - Seeking Alpha
- 15 days ago - Crescita Reports Second Quarter 2024 Results - Business Wire
- 4 weeks ago - Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years - Business Wire
- 4 weeks ago - Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement - Business Wire
- 5 weeks ago - Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World's Smallest Intradermal Delivery Device - Business Wire
- 2 months ago - Crescita Completes Acquisition of Strategic Assets of Occy Laboratory - Business Wire
- 2 months ago - Crescita to Acquire Strategic Assets of Occy Laboratory - Business Wire
- 2 months ago - Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders - Business Wire